Filter News
Area of Research
- (-) Nuclear Science and Technology (4)
- (-) Supercomputing (18)
- Advanced Manufacturing (9)
- Biology and Environment (22)
- Biology and Soft Matter (1)
- Building Technologies (1)
- Clean Energy (37)
- Climate and Environmental Systems (1)
- Computer Science (1)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (1)
- Fusion Energy (1)
- Isotopes (2)
- Materials (24)
- Materials for Computing (2)
- National Security (15)
- Neutron Science (4)
- Quantum information Science (2)
- Sensors and Controls (1)
News Topics
- (-) 3-D Printing/Advanced Manufacturing (1)
- (-) Climate Change (4)
- (-) Cybersecurity (3)
- (-) Frontier (9)
- (-) Isotopes (2)
- (-) Security (3)
- (-) Space Exploration (5)
- Advanced Reactors (5)
- Artificial Intelligence (14)
- Big Data (7)
- Bioenergy (4)
- Biology (5)
- Biomedical (7)
- Buildings (3)
- Chemical Sciences (2)
- Computer Science (39)
- Coronavirus (3)
- Critical Materials (2)
- Decarbonization (2)
- Energy Storage (4)
- Environment (5)
- Exascale Computing (8)
- Fusion (1)
- Grid (3)
- High-Performance Computing (8)
- Machine Learning (5)
- Materials (8)
- Materials Science (7)
- Microscopy (2)
- Molten Salt (3)
- Nanotechnology (4)
- National Security (3)
- Neutron Science (3)
- Nuclear Energy (15)
- Partnerships (1)
- Physics (3)
- Polymers (1)
- Quantum Computing (7)
- Quantum Science (9)
- Simulation (5)
- Summit (18)
- Sustainable Energy (4)
- Transportation (2)
Media Contacts
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.